TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MRNA

Moderna Inc

Healthcare · Biotechnology

172.90$ +12.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MRNA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-596.7% +571.9% -63.4% -162.6%
+0.0% +30,626.4% +35.9% +21.1% +24.8% +0.7% +642.4% +50.0% +78.4% -69.6% +13.8%
+1.8% +81.2% +11.8% +14.7% +52.7% +59.2% +35.0% +40.7% +12.6%
-92.7% +17,583.5% -1.7% +78.5% +10.9% +91.0% -213.2%
-160.7% -61.6% -449.0%
+76.2% +81.1% -70.2% +113.8% +321.1% +40.8% +76.8% +48.7% -81.7%
+0.0% -11,055,273.0% -189.5% -96.0% +11,087.2% +409.8% -39.3% -53.7% -0.2%
+134.3% +1,661.4% +48.4% +46.7%
-83.2% -100.0% +143.5% -12,273.3% +288.4% -65.4% -100.0%
+299.8% +0.0% +557.4% -89.7% -740.1% +2,152.6% +31.4% +46.7% -96.3%
-82.4% +47,191.0% -100.0% +730,163.1% -95.8% +3,877.2% -142.9% +295.0% -60.1% +958.9%
-71.4% -41,713.1% +517.5% -180.8% +76.9% -186.2%
-1,260.7% +580.6% -65.6% -183.5%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?